Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 10, 2004, Pages 1058-1071

  Chrétien, Fabrice ^a   Le Pavec, Gwenaelle ^b   Vallat Decouvelaere, Anne Valérie ^c   Delisle, Marie Bernadette ^d   Uro Coste, Emmanuelle ^d   Ironside, James W ^e   Gambetti, Pierluigi ^f   Parchi, Piero ^g   Créminon, Christophe ^h   Dormont, Dominique ^b   Mikol, Jacqueline ⁱ   Gray, Françoise ⁱ   Gras, Gabriel ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CHU RANGUEIL   (France)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h CEA SACLAY   (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Creutzfeldt Jakob disease; Excitatory amino acid transporter (EAAT); Fatal familial insomnia; Glutamate; Macrophage; Microglia; Prion diseases

Indexed keywords

AMINO ACID TRANSPORTER; CASPASE 3; CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLUTATHIONE; HLA DR ANTIGEN; INTERLEUKIN 1; METHIONINE; PRION PROTEIN; VALINE;

APOPTOSIS; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; CEREBELLUM; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CORPUS STRIATUM; CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; THALAMUS;

EID: 5644220074     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.10.1058     Document Type: Article

References (58)

1. Chrétien F, Vallat-Decouvelaere AV, Mikol J, Dormont D, Gras G, Gray F. Expression of glutamate transporter EAAT-1 by activated macrophages/microglia (AMM) in Creutzfeldt-Jakob disease (CJD) and fatal familial insomnia (FF1). Abstract from the XVth International Congress of Neuropathology, held in Turin, Italy, September 14-18, 2003. Brain Pathol 2003;13:S152
2. Gray F, Chrétien F, Vallat-Decouvelaere AV, Dormont D, Gras G, Mikol J. Expression of excitatory amino acid transporter-1 (EAAT-1) by activated macrophages/microglia (AMM) in the brain of patients with human immunodeficiency virus (HIV) infection and prion disease. (Abstract) Neuropathol Appl Neurobiol 2004;30:199
3. Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human transmissible spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459-66
4. Forloni G, Angeretti N, Chiesa R, et al. Neurotoxicity of prion protein fragment. Nature 1993;362:543-46
5. Giese A, Groschup MH, Hess B, Kretzschmar HA. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 1995;5:213-21
6. Dorandeu A, Wingertsmann L, Chrétien F, et al. Neuronal apoptosis in fatal familial insomnia. Brain Pathol 1998;8:531-37
7. Gray F, Chrétien F, Adle-Biassette H, et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1999;58:321-28
8. Lipton SA. HIV-related neurotoxicity. Brain Pathol 1991;1:193-99
9. Müller WEG, Ushijima H, Schröder HC, et al. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrPsc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993;246:261-67
10. Scallet AC, Ye X. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann NY Acad Sci 1997;825:194-205
11. Brown DR. Microglia and prion disease. Microsc Res Tech 2001;54:71-80
12. Adle-Biassette H, Chretien F, Wingertsmann L, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999;25:123-33
13. Adle-Biassette H, Levy Y, Colombel M, et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995;21:218-27
14. Gelbard HA, James HJ, Sharer LR, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995;21:208-17
15. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-30
16. Shi B, De Girolami U, He J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996;98:1979-90
17. Vallat AV, De Girolami U, He J, et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998;152:167-78
18. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-21
19. Boven LA, Gomes L, Hery C, et al. Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999;162:4319-27
20. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998;4:281-90
21. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988-94
22. Dreyer EB, Lipton SA. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 1995;7:2502-7
23. Fine SM, Angel RA, Perry SW, et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996;271:15303-6
24. Kort JJ. Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998;14:1329-39
25. Patton HK, Zhou ZH, Bubien JK, Benveniste EN, Benos DJ. gp120-induced alterations of human astrocyte function: Na(+)/ H(+) exchange, K(+) conductance, and glutamate flux. Am J Physiol Cell Physiol 2000;279:C700-708
26. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett 1997;411:107-9
27. Chrétien F, Vallat-Decouvelaere AV, Bossuet C, et al. Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol Appl Neurobiol 2002;28:410-17
28. Vallat-Decouvelaere AV, Chrétien F, Gras G, Le Pavec G, Dormont D, Gray F. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of hiv-infected patients. A neuroprotective role for activated microglia? J Neuropathol Exp Neurol 2003;62:429-40
29. Gras G, Chrétien F, Vallat-Decouvelaere AV, et al. Regulated expression of sodium-dependent glutamate transporters and glutamine synthetase: A neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol 2003;13:211-22
30. Rothstein JD, Martin L, Levey AI, et al. Localization of neuronal and glial glutamate transporters. Neuron 1994;13:713-25
31. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-86
32. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65:1-105
33. Rimaniol AC, Mialocq P, Clayette P, Dormont D, Gras G. Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol 2001;281:C1964-70
34. Reichelt W, Stabel-Burow J, Pannicke T, Weichen H, Heinemann U. The glutathione level of retinal Muller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience 1997;77:1213-24
35. Mikol J, Goutieres F, Delys JF, Parchi P. Growth hormone induced Creutzfeldt-Jakob disease (CJD) in a child with extensive lesions. (Abstract) Brain Pathol 1994;4:474
36. Buge A, Escourolle R, Brion S, et al. Maladie de Creutzfeldt-Jakob familiale: Étude clinique et anatomique de trois cas répartis sur trois générations. Transmission au singe écureuil. Rev Neurol (Paris), 1978;134:165-81
37. Monari L, Chen SG, Brown P, et al. Fatal Familial insomnia and familial Creutzfeldt-Jakob disease: Different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994;91:2839-42
38. Delisle MB, Haik S, Uro-Coste E, et al. Gerstmann-Sträussler- Scheinker disease presenting as corticobasal degeneration. (Abstract) J Neuropath Exp Neurol 2003;62:548
39. Medori R, Montagna P, Trischler HJ, et al. Fatal familial insomnia: A second kindred with mutation of the prion gene at codon 178. Neurology 1992;42:668-70
40. Manetto V, Medori R, Montagna P, et al. Fatal familial insomnia: Clinical and pathological study of five new cases. Neurology 1992;42:312-19
41. Rimaniol AC, Haik S, Martin M, et al. Na+-dependent high-affinity glutamate transport in macrophages. J Immunol 2000;164:5430-38
42. Bell JE, Gentleman SM, Ironside JW, et al. Prion protein immunocytochemistry-UK five centre consensus report. Neuropathol Appl Neurobiol 1997;23:26-35
43. Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E. Fatal familial insomnia and Creutzfeldt-jakob disease: Clinical pathological and molecular features. Brain Pathol 1995;5:43-51
44. DeArmond SJ, Ironside JW. Neuropathology of prion diseases. In: Prusiner SB, ed. Prion biology and diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999:585-652
45. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33
46. Lopez-Redondo F, Nakajima K, Honda S, Kohsaka S. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res Mol Brain Res 2000;76:429-35
47. van Landeghem FK, Stover JF, Bechmann I, et al. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 2001;35:167-79
48. Kondo K, Hashimoto H, Kitanaka J, et al. Expression of glutamate transporters in cultured glial cells. Neurosci Lett 1995;188:140-42
49. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci Lett 2001;307:171-74
50. Noda M, Nakanishi H, Akaike N. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 1999;92:1465-74
51. Brown DR. Prion protein peptide neurotoxicity can be mediated by astrocytes. J Neurochem 1999;73:1105-13
52. Brown DR, Mohn CM. Astrocytic glutamate uptake and prion protein expression. Glia 1999;25:282-92
53. Brown DR, Clive C, Haswell SJ. Antioxidant activity related to copper binding of native prion protein. J Neurochem 2001;76:69-76
54. Wong BS, Pan T, Liu T, et al. Prion disease: A loss of antioxidant function? Biochem Biophys Res Commun 2000;275:249-52
55. Brown DR, Kretzschmar HA. Microglia and prion disease: A review. Histol Histopathol 1997;12:883-92
56. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingected apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF. J Clin Invest 1998;101:890-98
57. Walsh DT, Betmouni S, Perry VH. Absence of detectable IL-1beta production in murine prion disease: A model of chronic neurodegeneration. J Neuropathol Exp Neurol 2001;60:173-82
58. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333-44